These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 21466751)
1. Cerebellar white-matter changes in cannabis users with and without schizophrenia. Solowij N; Yücel M; Respondek C; Whittle S; Lindsay E; Pantelis C; Lubman DI Psychol Med; 2011 Nov; 41(11):2349-59. PubMed ID: 21466751 [TBL] [Abstract][Full Text] [Related]
2. Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults. Cohen M; Rasser PE; Peck G; Carr VJ; Ward PB; Thompson PM; Johnston P; Baker A; Schall U Int J Neuropsychopharmacol; 2012 Apr; 15(3):297-307. PubMed ID: 21557880 [TBL] [Abstract][Full Text] [Related]
3. Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Cousijn J; Wiers RW; Ridderinkhof KR; van den Brink W; Veltman DJ; Goudriaan AE Neuroimage; 2012 Feb; 59(4):3845-51. PubMed ID: 21982932 [TBL] [Abstract][Full Text] [Related]
4. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia. Rais M; van Haren NE; Cahn W; Schnack HG; Lepage C; Collins L; Evans AC; Hulshoff Pol HE; Kahn RS Eur Neuropsychopharmacol; 2010 Dec; 20(12):855-65. PubMed ID: 20863671 [TBL] [Abstract][Full Text] [Related]
5. Regional brain abnormalities associated with long-term heavy cannabis use. Yücel M; Solowij N; Respondek C; Whittle S; Fornito A; Pantelis C; Lubman DI Arch Gen Psychiatry; 2008 Jun; 65(6):694-701. PubMed ID: 18519827 [TBL] [Abstract][Full Text] [Related]
6. Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia. Brans RG; van Haren NE; van Baal GC; Schnack HG; Kahn RS; Hulshoff Pol HE Arch Gen Psychiatry; 2008 Nov; 65(11):1259-68. PubMed ID: 18981337 [TBL] [Abstract][Full Text] [Related]
12. Association between a longer duration of illness, age and lower frontal lobe grey matter volume in schizophrenia. Premkumar P; Fannon D; Kuipers E; Cooke MA; Simmons A; Kumari V Behav Brain Res; 2008 Nov; 193(1):132-9. PubMed ID: 18586335 [TBL] [Abstract][Full Text] [Related]
13. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Rais M; Cahn W; Van Haren N; Schnack H; Caspers E; Hulshoff Pol H; Kahn R Am J Psychiatry; 2008 Apr; 165(4):490-6. PubMed ID: 18281413 [TBL] [Abstract][Full Text] [Related]
14. Recent-onset schizophrenia and adolescent cannabis use: MRI evidence for structural hyperconnectivity? Peters BD; de Haan L; Vlieger EJ; Majoie CB; den Heeten GJ; Linszen DH Psychopharmacol Bull; 2009; 42(2):75-88. PubMed ID: 19629024 [TBL] [Abstract][Full Text] [Related]
15. Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia. Dekker N; Schmitz N; Peters BD; van Amelsvoort TA; Linszen DH; de Haan L Psychiatry Res; 2010 Jan; 181(1):51-6. PubMed ID: 19962862 [TBL] [Abstract][Full Text] [Related]
16. Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls. Dekker N; Smeerdijk AM; Wiers RW; Duits JH; van Gelder G; Houben K; Schippers G; Linszen DH; de Haan L Psychol Med; 2010 Aug; 40(8):1325-36. PubMed ID: 19917142 [TBL] [Abstract][Full Text] [Related]
17. Differential impact of heavy cannabis use on sensory gating in schizophrenic patients and otherwise healthy controls. Rentzsch J; Penzhorn A; Kernbichler K; Plöckl D; Gómez-Carrillo de Castro A; Gallinat J; Jockers-Scherübl MC Exp Neurol; 2007 May; 205(1):241-9. PubMed ID: 17368620 [TBL] [Abstract][Full Text] [Related]
18. Reduced cerebellar volume and neurological soft signs in first-episode schizophrenia. Bottmer C; Bachmann S; Pantel J; Essig M; Amann M; Schad LR; Magnotta V; Schröder J Psychiatry Res; 2005 Dec; 140(3):239-50. PubMed ID: 16288852 [TBL] [Abstract][Full Text] [Related]
19. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725 [TBL] [Abstract][Full Text] [Related]
20. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]